AxiaMed Revenue and Competitors

Location

$15.8M

Total Funding

Estimated Revenue & Valuation

  • AxiaMed's estimated annual revenue is currently $2.8M per year.(i)
  • AxiaMed's estimated revenue per employee is $135,000
  • AxiaMed's total funding is $15.8M.

Employee Data

  • AxiaMed has 21 Employees.(i)
  • AxiaMed grew their employee count by 0% last year.

AxiaMed's People

NameTitleEmail/Phone
1
CTOReveal Email/Phone
2
Technical Support ManagerReveal Email/Phone
3
Manager, Implementation & DeploymentReveal Email/Phone
4
Software EngineerReveal Email/Phone
5
Technical Support Specialist - Tier 2Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$254.2M12007%$13.7M$796.9M
#2
$58.8M336N/AN/AN/A
#3
$374.2M1909N/AN/AN/A
#4
$228.6M11428%$45MN/A
#5
$17.3M119-8%$18.2MN/A
#6
$13.9M96-5%N/AN/A
#7
$10.7M7222%N/AN/A
#8
$12.3M85N/AN/AN/A
#9
$1.3M17N/AN/AN/A
#10
$1.5M17N/AN/AN/A
#11
$30.8M114N/AN/AN/A
#12
$173.6M8557%N/AN/A
#13
$36.5M0N/A$43.5MN/A
#14
$1.4M16N/AN/AN/A
#15
$14.1M101-13%$21.5MN/A
#16
$22.4M16014%$35MN/A
#17
$0.3M7N/AN/AN/A
#18
$66.5M224N/AN/AN/A
#19
$295.8M1457N/AN/AN/A
#20
$1.1M9N/AN/AN/A
Add Company

What Is AxiaMed?

Simplifying patient payments is the heart of what we do for our healthcare providers. As a healthcare payments technology company, medical providers are not only our patients but our partners as well. You take care of the patients, and we take care of you. \r\n\r\nWhen our healthcare providers expressed their desire for a platform that would make collecting patient payments swift and easy, we formulated the ideal prescription. \r\n\r\nAxiaMed provides integrated healthcare payments technology for healthcare IT companies to streamline workflow and simplify collecting patient payments.\r\nOur industry leading technology solutions for software providers (ISVs) and clients offer an unparalleled single integration point and a secure, flexible platform. \r\n\r\nA One-on-One Relationship with your Trusted Advisor\r\nWe take a consultative approach to help our partners and clients solve problems related to patient payments and all aspects of payments management.\r\n\r\nIndustry-leading Technology and Security\r\nWe constantly research and provide emerging payment technologies and methodologies to enhance functionality along with workflow.\r\n\r\nTrusted for over Two Decades\r\nAxiaMed boasts unparalleled retention rates. This is a direct result of the boutique style of exceptional support and service that we provide. AxiaMed’s team of healthcare transaction experts continually work with our partners and clients to solve complex payments issues.\r\n\r\nWhat we do is simple: we take the pain out of patient payments.

keywords:N/A

$15.8M

Total Funding

21

Number of Employees

$2.8M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

AxiaMed News

2018-08-21 - Revenue Cycle Startup AxiaMed Lands $12.4M for Patient Payment Platform

AxiaMed, a patient payment solution provider has raised $12.4 million in funding from Health Enterprise Partners. AxiaMed credits this investment to rapidly-increasing demand for its proven, secure, SaaS-based payment platform, Payment Fusion. Founded in 2015, AxiaMed’s integrated payments tech ...

2018-08-19 - HEP Leads $12.4M Funding for AxiaMed

SANTA BARBARA, Calif.--(BUSINESS WIRE)--AxiaMed, an innovative healthcare payments technology company, announced today that it has raised $12.4 million in funding to accelerate its growth in the burgeoning market for secure, flexible patient payments. Health Enterprise Partners (HEP) led the rou ...

2018-08-15 - Healthcare Payments Tech Company AxiaMed Raises $12.4M

AxiaMed, a Santa Barbara, CA-based innovative healthcare payments technology company, raised $12.4m in funding. The round was led by Health Enterprise Partners (HEP) with participation from existing investors including Nashville Capital Network. The company intends to use the funds to increase ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.4M215%N/A
#2
$2.1M21-22%N/A
#3
$3.5M22-41%N/A
#4
$2.3M230%N/A
#5
$2.3M2321%N/A